Human monocyte activation by cleaved form of alpha‐1‐antitrypsin
- 1 November 1999
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 265 (3) , 875-882
- https://doi.org/10.1046/j.1432-1327.1999.00821.x
Abstract
Production of alpha-1-antitrypsin (AAT) by human monocytes is an important factor in controlling tissue damage by proteases in the microenvironment of inflammation. Increases, of four- to eightfold, in numbers of macrophages and levels of AAT and its cleavage fragments have been found in various inflammatory loci. We have found that the C-terminal peptide (C-36) of AAT, produced by specific proteinase cleavage when added in its fibrillar form at concentrations ≥5 µm to monocytes in culture for 24 h, significantly increases low density lipoprotein (LDL) binding and uptake, up-regulates levels of LDL receptors and also induces proinflammatory cytokine (interleukin-1, interleukin-6 and tumour necrosis factor α) production and glutathione reductase activity. Because it is known that various cells selectively internalize surface receptors and their ligands through receptor-mediated endocytosis via clathrin-coated pits, we tested whether antibodies raised against the clathrin heavy chain would block the effects of the fibrillar form of C-36 on human monocytes in culture. Addition of excess anti-(clathrin HC) with 10 µm fibrillar C-36 diminished the stimulatory effects of the latter on LDL binding, uptake and LDL receptor levels. In contrast, however, in the presence of anti-(clathrin HC), the potentially cytotoxic effects of fibrils, such as induction of cytokines, free radicals and cytosolic activity of cathepsin D, were much greater than those observed when cells were treated with fibrils alone. These results suggest that endocytosis is the pathway by which C-36 fibrils upregulate LDL receptors, and may be the natural mechanism for fibril clearance. We infer that human monocytes clear C-36 fibrils by a clathrin-dependent pathway, presumably endocytotic, and that loss of this pathway amplifies the cytotoxic effects of the fibrils by increasing their availability to other specific or nonspecific sites through which they exert their cytotoxic effects.Keywords
This publication has 55 references indexed in Scilit:
- Effects of Fibrillar C–Terminal Fragment of Cleaved α1–Antitrypsin on Cholesterol Homeostasis in Hepg2 CellsHepatology, 1999
- Specific Activity of α1Proteinase Inhibitor and α2Macroglobulin in Human Serum: Application to Insulin-Dependent Diabetes MellitusClinical Immunology and Immunopathology, 1998
- Clathrin Coats— Threads Laid BareCell, 1998
- Conformational diseaseThe Lancet, 1997
- Effects of Serpin Binding on the Target Proteinase: Global Stabilization, Localized Increased Structural Flexibility, and Conserved Hydrogen Bonding at the Active SiteBiochemistry, 1997
- Pore Formation by the Cytotoxic Islet Amyloid Peptide AmylinJournal of Biological Chemistry, 1996
- Identification of hydrophobic fragments of α1‐antitrypsin and Cl protease inhibitor in human bile, plasma and spleenFEBS Letters, 1992
- Proteolytic inactivation of human α1 antitrypsin by human stromelysinFEBS Letters, 1991
- Inhibition of endocytosis by anti-clathrin antibodiesCell, 1987
- Inactivation of human plasma α1-proteinase inhibitor by a metalloproteinase from serratia marcescensBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982